2027

Popular stocks:

GameStop

Zomedica

Churchill Capital Corp IV

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Zynerba (ZYNE) stock forecast for 2021

The forecast has been updated: March 23, 2023 7:39

Zynerba stock price online today

Analyst Target Price

5.44

Dividend Date

Ex Dividend Date

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2021? How much will it cost in 2021? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $5.44 target price for Zynerba stock stock.

Today 200 Day Moving Average is the resistance level (0.813 $).

50 Day Moving Average is the resistance level (0.54 $).

2027

ZYNE Forecast for 2021

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.

Zynerba overview

Zynerba Address

80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US

Market Capitalization

20 081 700 $

EBITDA

-35 174 184

PE Ratio

None

PEG Ratio

Dividend Per Share

Dividend Yield

EPS

-0.87

Quarterly Earnings Growth YOY

Quarterly Revenue Growth YOY

Trailing PE

Forward PE

EV To Revenue

397.61

EV To EBITDA

0.776

52 Week High

2.28

52 Week Low

0.39

50 Day Moving Average

0.54

200 Day Moving Average

0.813

Shares Outstanding

47062700

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Zynerba stock forecast for this year

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Other Healthcare sector assets

Name	Symbol	Last Close Price	Change
Abbott Laboratories	ABT	98.46 (27.03.2023)	0.42 %
AbbVie Inc.	ABBV	157.54 (27.03.2023)	-0.30 %
Aeterna Zentaris Inc.	AEZS	2.63 (27.03.2023)	-0.38 %
Allakos Inc.	ALLK	4.55 (27.03.2023)	-1.30 %
Allogene Therapeutics, Inc.	ALLO	5.03 (27.03.2023)	0.20 %
Amgen Inc.	AMGN	236.76 (27.03.2023)	-0.53 %
Aphria Inc.	APHA	15.38 (07.05.2021)	0.00 %
Atara Biotherapeutics, Inc.	ATRA	2.97 (27.03.2023)	3.48 %
Aurora Cannabis Inc.	ACB	0.7074 (27.03.2023)	0.41 %
Becton Dickinson and Company	BDX	242.18 (27.03.2023)	0.70 %
Biogen Inc.	BIIB	269.98 (27.03.2023)	-0.02 %
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	14.29 (24.03.2023)	6.64 %
BioNTech SE	BNTX	123.6 (27.03.2023)	-3.59 %
bluebird bio, Inc.	BLUE	4.51 (27.03.2023)	1.81 %
Boston Scientific Corp.	BSX	48.33 (27.03.2023)	0.23 %
Bristol-Myers Squibb Company	BMY	68.07 (27.03.2023)	0.58 %
Canopy Growth Corp.	CGC	1.88 (27.03.2023)	-1.05 %
Castle Biosciences, Inc.	CSTL	22.63 (27.03.2023)	0.53 %
CLOVER HEALTH INVESTMENTS, CORP	CLOV	3.16 (07.01.2022)	-5.67 %
Eli Lilly and Company	LLY	242.27 (04.02.2022)	0.00 %
Emergent BioSolutions Inc.	EBS	8.86 (27.03.2023)	9.38 %
Exelixis, Inc.	EXEL	18.56 (17.06.2022)	5.63 %
G1 Therapeutics, Inc.	GTHX	2.79 (27.03.2023)	8.56 %
Gilead Sciences, Inc.	GILD	79.58 (27.03.2023)	-0.52 %
GlaxoSmithKline plc	GSK	35.04 (27.03.2023)	1.92 %
GoodRx Holdings, Inc.	GDRX	6.15 (27.03.2023)	-3.61 %
GW Pharmaceuticals plc.	GWPH	218.96 (05.05.2021)	0.00 %
Incyte Corp.	INCY	70.81 (27.03.2023)	0.83 %
Inovio Pharmaceuticals, Inc.	INO	0.9137 (27.03.2023)	-5.07 %
Johnson & Johnson	JNJ	153.3 (27.03.2023)	0.43 %
Medtronic plc.	MDT	79.64 (27.03.2023)	0.34 %
Merck & Co., Inc.	MRK	106.93 (27.03.2023)	2.03 %
Moderna, Inc.	MRNA	148.35 (27.03.2023)	-1.68 %
Novartis AG	NVS	90.28 (27.03.2023)	8.00 %
Novavax, Inc.	NVAX	6.09 (27.03.2023)	0.83 %
ObsEva SA	OBSV	0.08 (27.03.2023)	-21.41 %
OrganiGram Holdings Inc.	OGI	0.644 (27.03.2023)	1.77 %
Pfizer Inc.	PFE	40.22 (27.03.2023)	-0.42 %
Regeneron Pharmaceuticals, Inc.	REGN	820.41 (27.03.2023)	0.05 %
Sanofi	SNY	53.22 (27.03.2023)	1.16 %
Schrodinger, Inc.	SDGR	25.62 (27.03.2023)	0.20 %
Senseonics Holdings, Inc.	SENS	0.7103 (27.03.2023)	-0.71 %
Sorrento Therapeutics, Inc.	SRNE	0.3251 (27.03.2023)	-4.38 %
Stryker Corp.	SYK	278.11 (27.03.2023)	0.51 %
Sundial Growers Inc.	SNDL	1.545 (27.03.2023)	-1.59 %
Teva Pharmaceutical Industries Lim. (TEVA)	TEVA	8.73 (27.03.2023)	3.44 %
Thermo Fisher Scientific Inc.	TMO	561.69 (27.03.2023)	0.61 %
Tilray, Inc.	TLRY	2.61 (27.03.2023)	-0.38 %
UnitedHealth Group, Inc.	UNH	481.9 (27.03.2023)	1.24 %
Veeva Systems Inc.	VEEV	177.54 (27.03.2023)	1.12 %
Zomedica Corp.	ZOM	0.21 (27.03.2023)	0.00 %
Zynerba Pharmaceuticals, Inc.	ZYNE	0.41 (27.03.2023)	-4.70 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.